AHZ Revisited

After years of poor performing management and wasting $millions of shareholders money, I suspect AHZ is on the cusp of fulfilling some of it's delayed potential. There is a constant uplift in ADAPT sales and with the imminent release of their new product, I suspect that the market will see the "true" potential of this stock, without constantly looking at the past. I too agree with many others, that WP has made statements, but not delivered on time and budget, however biotech is a tough business placed in a tough market and there now seems some positives coming from the group. Time will tell of course and it has been a long road, a long painful road. I and I am sure, many other long term holders who were sitting on "hold" are now thinking of hitting the "buy" button, cautiously, to average down and take advantage of what looks like, a bright future. Lets face it, on a world scale, AHZ is outrageously cheap, even considering the past stumbles, I am thinking the "worm is turning"! My opinion only, not advice! GLTA